NasdaqCM - Delayed Quote • USD
Check-Cap Ltd. (CHEK)
At close: April 23 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -0.87 | 0 | -3.25 | -2.59 |
| Low Estimate | -0.87 | 0 | -3.25 | -2.59 |
| High Estimate | -0.87 | 0 | -3.25 | -2.59 |
| Year Ago EPS | -0.63 | -0.76 | -3.37 | -3.25 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.68 | -0.54 | -0.45 | -0.29 |
| EPS Actual | -0.63 | -0.76 | -1.18 | -0.44 |
| Difference | 0.05 | -0.22 | -0.73 | -0.15 |
| Surprise % | 7.40% | -40.70% | -162.20% | -51.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | -0.87 | 0 | -3.25 | -2.59 |
| 7 Days Ago | -0.87 | -0.17 | -3.25 | -2.59 |
| 30 Days Ago | -0.87 | -0.17 | -3.25 | -2.59 |
| 60 Days Ago | -0.87 | -0.17 | -3.25 | -2.59 |
| 90 Days Ago | -0.52 | -0.17 | -2.76 | -1.63 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CHEK | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -38.10% | -- | -- | 0.40% |
| Next Qtr. | -- | -- | -- | 9.90% |
| Current Year | 3.60% | -- | -- | 4.30% |
| Next Year | 20.30% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 6/7/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 4/5/2023 |
| Maintains | HC Wainwright & Co.: Buy | 8/9/2021 |
| Downgrade | Dawson James: Buy to Neutral | 3/17/2021 |
| Maintains | HC Wainwright & Co.: Buy | 3/16/2021 |
Related Tickers
ISPC iSpecimen Inc.
0.2951
-13.21%
NDRA ENDRA Life Sciences Inc.
0.2544
+2.91%
GENE Genetic Technologies Limited
2.3900
+0.84%
E08A.F Exagen Inc.
1.2900
0.00%
ANPCF ANGLE plc
0.2340
0.00%
ANPCY ANGLE plc
1.8900
0.00%
SZLSF StageZero Life Sciences Ltd.
0.0270
0.00%
OPK OPKO Health, Inc.
1.2500
+1.63%
SYAB.DE SYNLAB AG
10.58
+0.57%
CORBF Global Cord Blood Corporation
1.3500
0.00%